Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDELYX, INC. Director's Dealing 2014

Jun 19, 2014

32003_dirs_2014-06-19_fbb144b8-2a94-4884-aa3e-f16c656665d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2014-06-18

Reporting Person: SCHULTZ PETER G (Director)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 53900 Direct
Common Stock 26949 Indirect
Common Stock 26949 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series A Preferred Stock $0.00 Common Stock (289141) Direct
Series B Preferred Stock $0.00 Common Stock (457249) Direct
Series B Preferred Stock Purchase Warrant $0.09 2020-11-16 Series B Preferred Stock (45602) Direct
Series B Preferred Stock Purchase Warrant $0.09 2021-04-14 Series B Preferred Stock (15200) Direct

Footnotes

F1: Reflects a one-for-nine reverse split of the Issuer's stock effected immediately prior to the consummation of the Issuer's initial public offering.

F2: The shares are directly held by Schultz Children's Trust Kathryn.

F3: The shares are directly held by Schultz Children's Trust Nathan.

F4: Each share of Series A and Series B Preferred Stock will automatically convert on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.

F5: The securities are immediately convertible or exercisable, as applicable.

F6: The expiration date is not relevant to the conversion of these securities.

F7: The Series B Preferred Stock Purchase Warrants will be automatically exercised on a net basis into shares of Series B Preferred Stock based on the final public offering price of the Company's Common Stock immediately prior to the consummation of the Issuer's initial public offering. Such warrants cease to be exercisable following such initial public offering.